Cypher sirolimus-eluting stent: Pivotal

JNJ’s Cordis Corp. subsidiary said 9-month safety data from the U.S. double-blind SIRIUS study in 1,058 evaluable patients showed an incidence of death of 0.8% for patients given Cypher and 0.6% for p...